These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38696997)

  • 1. Long term impact of transjugular intrahepatic portosystemic shunt (TIPS) creation on hepatic morphology.
    Gupta VF; Benvenuti T; Ronald J; Cline BC; Befera NT; Martin JG; Pabon-Ramos WM; Sag AA; Smith TP; Suhocki PV; Kim CY
    Clin Imaging; 2024 Jun; 110():110142. PubMed ID: 38696997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of transjugular intrahepatic portosystemic shunt creation for flow-enabled dissolution of spleno-mesenterico-portal venous thrombosis.
    Lakhoo J; Gaba RC
    Diagn Interv Imaging; 2016 Nov; 97(11):1085-1093. PubMed ID: 27481577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transjugular intrahepatic portosystemic shunt creation may be associated with hyperplastic hepatic nodular lesions in the long term: an analysis of 18 pediatric and young adult patients.
    Woerner AJ; Shin DS; Chick JFB; Koo KSH; Hsu EK; Tang ER; Monroe EJ
    Pediatr Radiol; 2021 Jul; 51(8):1348-1357. PubMed ID: 33783576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in hepatic arterial blood flow after transjugular intrahepatic portosystemic shunt creation and its potential predictive value of postprocedural encephalopathy and mortality.
    Patel NH; Sasadeusz KJ; Seshadri R; Chalasani N; Shah H; Johnson MS; Namyslowski J; Moresco KP; Trerotola SO
    J Vasc Interv Radiol; 2001 Nov; 12(11):1279-84. PubMed ID: 11698626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of transjugular intrahepatic portosystemic shunt creation on intermediate-term model for end-stage liver disease score progression.
    Casadaban LC; Gabra MG; Parvinian A; Minocha J; Knuttinen MG; Bui JT; Gaba RC
    Transplant Proc; 2014 Jun; 46(5):1384-8. PubMed ID: 24935301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications.
    Chen Y; Ye P; Li Y; Ma S; Zhao J; Zeng Q
    Eur Radiol; 2015 Dec; 25(12):3431-7. PubMed ID: 25903717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoas Muscle Density in Combination with Model for End-Stage Liver Disease Score Can Improve Survival Predictability in Transjugular Intrahepatic Portosystemic Shunts.
    Shoreibah MG; Mahmoud K; Aboueldahab NA; Vande Lune P; Massoud M; Bae S; El Khudari H; Gunn AJ; Abdel Aal AK
    J Vasc Interv Radiol; 2019 Feb; 30(2):154-161. PubMed ID: 30717946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transjugular intrahepatic portosystemic shunt creation (TIPS) in the angio-CT-a hybrid intervention with image fusion.
    Nadjiri J; Waggershauser T; Mühlmann M; Ehmer U; Geisler F; Mayr U; Geith T; Paprottka PM
    Eur Radiol; 2023 Nov; 33(11):7380-7387. PubMed ID: 37284864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between portal/hepatic vein gradient and response to transjugular intrahepatic portosystemic shunt creation in refractory ascites.
    Nair S; Singh R; Yoselewitz M
    J Vasc Interv Radiol; 2004 Dec; 15(12):1431-4. PubMed ID: 15590801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transjugular Intrahepatic Portosystemic Shunt Through the Strut of a Previously Placed Stent: Technical Feasibility and Long-Term Follow-Up Results.
    Ahmed M; Keshava SN; Moses V; Chiramel GK; Mammen S; Eapen CE; Zachariah UG
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1794-1798. PubMed ID: 30014251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation.
    Ronald J; Wang Q; Choi SS; Suhocki PV; Hall MD; Smith TP; Kim CY
    Diagn Interv Imaging; 2018 Mar; 99(3):163-168. PubMed ID: 29154015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of transjugular intrahepatic portosystemic shunt implantation on liver perfusion measured by volume perfusion CT.
    Preibsch H; Spira D; Thaiss WM; Syha R; Nikolaou K; Ketelsen D; Lauer UM; Horger M
    Acta Radiol; 2017 Oct; 58(10):1167-1173. PubMed ID: 28084812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
    Saad WE; Darwish WM; Davies MG; Waldman DL
    J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.
    Luo J; Li M; Zhang Y; Wang H; Huang M; Li Z; Chen J; Wu C; Qian J; Guan S; Jiang Z
    Eur Radiol; 2018 Sep; 28(9):3661-3668. PubMed ID: 29600476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation.
    Gaba RC; Couture PM; Bui JT; Knuttinen MG; Walzer NM; Kallwitz ER; Berkes JL; Cotler SJ
    J Vasc Interv Radiol; 2013 Mar; 24(3):411-20, 420.e1-4; quiz 421. PubMed ID: 23312989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes and Patency after Transjugular Intrahepatic Portosystemic Shunt Reduction for Overshunting Adverse Events.
    Shah RJ; Alqadi MM; Duvvuri M; Kim YJ; Tyagi R; Lokken RP; Gaba RC
    J Vasc Interv Radiol; 2022 Dec; 33(12):1507-1512. PubMed ID: 35964879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Segmental liver ischemia/infarction after elective transjugular intrahepatic portosystemic shunt creation: clinical outcomes in 10 patients.
    Lopera JE; Katabathina V; Bosworth B; Garg D; Kroma G; Garza-Berlanga A; Suri R; Wholey M
    J Vasc Interv Radiol; 2015 Jun; 26(6):835-41. PubMed ID: 25661437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Older patient age may predict early mortality after transjugular intrahepatic portosystemic shunt creation in individuals at intermediate risk.
    Parvinian A; Shah KD; Couture PM; Minocha J; Knuttinen MG; Bui JT; Gaba RC
    J Vasc Interv Radiol; 2013 Jul; 24(7):941-6. PubMed ID: 23707226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portal flow and arterioportal shunting after transjugular intrahepatic portosystemic shunt creation.
    Itkin M; Trerotola SO; Stavropoulos SW; Patel A; Mondschein JI; Soulen MC; Tuite CM; Shlansky-Goldberg RD; Faust TW; Reddy KR; Solomon JA; Clark TW
    J Vasc Interv Radiol; 2006 Jan; 17(1):55-62. PubMed ID: 16415133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal portal venous flow at sonography predicts reduced survival after transjugular intrahepatic portosystemic shunt creation.
    Harrod-Kim P; Waldman DL
    J Vasc Interv Radiol; 2005 Nov; 16(11):1459-64. PubMed ID: 16319151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.